Vaccines

What in June 2020 was an observation trickling through Europe’s medical community is now solidifying as a global trend: young to middle-aged women are most vulnerable to long COVID, 

The Novavax COVID-19 vaccine has shown high efficacy—90.4% overall—against the disease in its Phase 3 trial, the company announced today.    The not-yet-peer-reviewed results:

America’s pandemic response, like the country itself, “valorizes independence and prizes personal freedom”—no matter the administration.   The trait has hobbled the US strategy—most recently with new CDC guidance that focuses on the vaccinated being “liberated from the…

Leaders of the G-7 industrialized nations are expected to pledge 1 billion COVID-19 vaccine doses today in a move that will help low- and middle-income countries but still fall short of—and arrive later than—what’s needed. 

Dengue cases were slashed 77% in a new trial infecting mozzies with the “miraculous” Wolbachia bacteria that hinders the virus’s progression.  

The Delta coronavirus variant, with a dramatic transmission advantage over the Alpha variant that emerged in the UK, threatens global plans for dispatching COVID-19, 

A documentary released in March by Robert F.

The UN agreed yesterday on ambitious new goals for ending the AIDS pandemic by 2030—despite eleventh hour attempts by some delegates to water down protections for high-risk groups,

“I think everyone who wants it has already gotten it,” a health worker was told, holding a cooler of soon-to-expire COVID-19 vaccines doses. All went unused.    

When COVID-19 hit, some med students were given the option to graduate early to join the fight.   Knowing that their entry into the profession would be less comfort and healing and more war zone, they nicknamed their cohorts “Coalition Forces” and “Covid Army.”